Comparison of compound muscle action potential amplitude the between pateints with motor neuron disease and those with lower motor neuron disease

LIU Xiaoxuan,FAN Dongsheng,ZHANG Jun
DOI: https://doi.org/10.3969/j.issn.1674-8972.2006.03.001
2006-01-01
Abstract:Objective: The prognosis of definite ALS is the worst. Lower motor neuron diseases (LMNS) meets the criteria for suspected ALS. Recent studies show treatable diseases can mimic early MND. This study fucoses on compound muscle action potential(CMAP) amplitude changes to attempt to differentiate the possible ALS from typical ALS. Methods: The following data were obtained through 112 amyotrophic lateral sclerosis (ALS). Three groups can be distinguished:(1) definite ALS (43) (2) possible ALS(38) (3) suspected ALS (31). All patients were performing standard EMG and nerve conduction measurement. Results:The patients with reduced CMAP amplitude were more in Group 1 than in Group 3 (X2 =4. 938,P<0. 05), but the degree of the reduced CMAP amplitude was no significantly different(t= 0.815,P>0.05). In suspected patients ,there were 3 different aspects compared with the typical ALS. (1)So far as the obviously declined amplitude within first 6 months,the muscle strength was not compatible with the amplitude change;(2) The reduction of amplitude was severe during 2 years from the onset of the symptom, but their EMG impairment was relatively focal;(3)The relative normal amplitude in the patients with the lenger course of the disease(more than 2 years). We can consider (1) and (2) as MMN and CMAN, (3) as PMA or SMA. Conclusion:CMAP amplitude may be a sensitive index for documenting changes in LMNS progression with the length of time and play a very important role in diagnosis, differentiation and prognosis.
What problem does this paper attempt to address?